UNIVERSITY of CALIFORNIA, SAN DIEGO SAN DIEGO STATE UNIVERSITY Beta-Hairpin Fusion to Alpha-Helical Domains for Exploring Recomb

Total Page:16

File Type:pdf, Size:1020Kb

UNIVERSITY of CALIFORNIA, SAN DIEGO SAN DIEGO STATE UNIVERSITY Beta-Hairpin Fusion to Alpha-Helical Domains for Exploring Recomb UNIVERSITY OF CALIFORNIA, SAN DIEGO SAN DIEGO STATE UNIVERSITY Beta-Hairpin Fusion to Alpha-Helical Domains for Exploring Recombinant Protein Stability in E. coli A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Chemistry by Melissa E. Lokensgard Committee in Charge: University of California, San Diego Professor Elizabeth Komives Professor Ross Walker San Diego State University Professor John Love, Chair Professor Tom Huxford Professor Roland Wolkowicz 2016 Copyright Melissa E. Lokensgard, 2016 All Rights Reserved The Dissertation of Melissa E. Lokensgard is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Chair SIGNATURE PAGE University of California, San Diego San Diego State University 2016 iii DEDICATION For Matt, Mom, and Dad. But mostly for me. iv TABLE OF CONTENTS Signature Page .............................................................................................................. iii Dedication ..................................................................................................................... iv Table of Contents ............................................................................................................ v List of Figures ............................................................................................................. viii List of Tables .................................................................................................................. x Acknowledgements ....................................................................................................... xi Vita .............................................................................................................................. xiii Abstract of the Dissertation ........................................................................................ xiv Chapter 1: Introduction ................................................................................................... 1 1.2 Perspective .......................................................................................................... 2 1.3 Target Definition ................................................................................................. 3 1.4 Four Small Domains for Protein Design ............................................................. 4 1.4.1 Protein A .................................................................................................... 5 1.4.2 Protein G .................................................................................................... 6 1.4.3 Ubiquitin .................................................................................................... 8 1.4.4 Engrailed .................................................................................................... 9 1.5 References ......................................................................................................... 20 Chapter 2: Fusion of β-hairpins to α-helical domains enhances recombinant expression accumulation by reducing effectiveness of host degradation stress response .............. 22 2.1 Introduction ....................................................................................................... 23 2.2 Materials and Methods ...................................................................................... 25 2.2.1 Molecular Cloning, Expression, and Purification .................................... 25 v 2.2.2 Expression Quantification ........................................................................ 26 2.2.3 Circular Dichroism (CD) ......................................................................... 27 2.2.4 Microscale Thermophoresis (MST) ......................................................... 28 2.2.5 Nuclear Magnetic Resonance .................................................................. 29 2.3 Results ............................................................................................................... 33 2.3.1 Increased expression of helical constructs in BL21(DE3) cytosol with added b-hairpin sequence ................................................................................. 33 2.3.2 Helical domains with b-hairpins contain added b character .................... 37 2.3.3 Unfolding of helical domain is unaffected by added b-hairpins .............. 41 2.3.4 b-Hairpins influence interactions with E. coli ClpS ................................ 48 2.4 Discussion ......................................................................................................... 53 2.4.1 Small helical domains can be vulnerable in the E. coli cytosol ............... 53 2.4.2 b-Hairpin sequences from stable domains can act as miniature tags without affecting protein architecture or stability ............................................. 55 2.5 Conclusions ....................................................................................................... 57 2.6 Future Direction ................................................................................................ 57 2.6.1 Nuclear Magnetic Resonance .................................................................. 58 2.6.2 Full-length Fusions .................................................................................. 58 2.6.3 Further explorations of the Clp system .................................................... 60 2.7 Acknowledgment .............................................................................................. 61 2.8 References ......................................................................................................... 62 Chapter 3: Circular Dichroism Spectroscopy of Pyrrolopyrimidine Derivatives and Nucleic Acids ................................................................................................................ 66 vi 3.1 Use of Circular Dichroism Spectroscopy to Assign Configurations of Atropisomeric Pyrrolopyrimidine Derivatives ....................................................... 67 3.1.1 Introduction .............................................................................................. 67 3.1.2 Methods.................................................................................................... 68 3.1.3 Results and Discussion ............................................................................ 69 3.1.4 Conclusions .............................................................................................. 76 3.2 Circular Dichroism Spectroscopy for Thermodynamic Characterization of Novel Fluorescent Oligonucleotides ....................................................................... 77 3.2.1 Introduction .............................................................................................. 77 3.2.2 Methods.................................................................................................... 78 3.2.3 Results and Discussion ............................................................................ 78 3.2.4 Conclusions .............................................................................................. 87 3.4 References ......................................................................................................... 88 vii LIST OF FIGURES Figure 1.1 Staphylococcal Protein A (SpA) ................................................................. 11 Figure 1.2 SpA IgG Fc contacts .................................................................................... 12 Figure 1.3 SpA and SpA(I17W) models ....................................................................... 13 Figure 1.4 Streptococcal Protein G ............................................................................... 14 Figure 1.5 Gβ1 IgG Fc contacts .................................................................................... 15 Figure 1.6 Primary amino acid sequences of Love Lab Gβ1 variants .......................... 16 Figure 1.7 Backbone alignment of Ub and Gβ1 domains ............................................. 17 Figure 1.8 En homeodomain DNA contacts ................................................................. 18 Figure 1.9 En destabilized variants I41V and I41A ...................................................... 19 Figure 2.1 Primary Amino Acid Sequences of Constructs ........................................... 31 Figure 2.2 Sequences and secondary structures of parent domains .............................. 32 Figure 2.3 Expression levels of β-hairpin fusions to SpA ............................................ 34 Figure 2.4 Expression levels of β-hairpin fusions to En ............................................... 35 Figure 2.5 Expression levels of destabilized variants ................................................... 36 Figure 2.6 Circular Dichroism spectra of SpA variants ................................................ 38 Figure 2.7 Circular Dichroism spectra of En variants .................................................. 39 Figure 2.8 Thermal denaturation curves of SpA variants. ............................................ 42 Figure 2.9 Thermal denaturation curves of En variants ................................................ 43 Figure 2.10 Spectral response to temperature of SpA variants ..................................... 45 Figure 2.11 15N-1H HSQC spectrum of SpA-NH. ........................................................ 46 Figure 2.12 15N-1H HSQC spectrum of NH-SpA. ........................................................ 47 Figure 2.13 Raw MST
Recommended publications
  • Highly Efficient Purification of Protein Complexes from Mammalian Cells
    Highly efficient purification of protein complexes from mammalian cells using a novel streptavidin-binding peptide and hexahistidine tandem tag system: Application to Bruton’s tyrosine kinase Yifeng Li,1 Sarah Franklin,1 Michael J. Zhang,1 and Thomas M. Vondriska1,2,3* 1Department of Anesthesiology, David Geffen School of Medicine, University of California, Los Angeles, CA 2Department of Medicine/Cardiology, David Geffen School of Medicine, University of California, Los Angeles, CA 3Department of Physiology, David Geffen School of Medicine, University of California, Los Angeles, CA Received 2 June 2010; Revised 9 September 2010; Accepted 27 October 2010 DOI: 10.1002/pro.546 Published online 15 November 2010 proteinscience.org Abstract: Tandem affinity purification (TAP) is a generic approach for the purification of protein complexes. The key advantage of TAP is the engineering of dual affinity tags that, when attached to the protein of interest, allow purification of the target protein along with its binding partners through two consecutive purification steps. The tandem tag used in the original method consists of two IgG-binding units of protein A from Staphylococcus aureus (ProtA) and the calmodulin- binding peptide (CBP), and it allows for recovery of 20–30% of the bait protein in yeast. When applied to higher eukaryotes, however, this classical TAP tag suffers from low yields. To improve protein recovery in systems other than yeast, we describe herein the development of a three-tag system comprised of CBP, streptavidin-binding peptide (SBP) and hexa-histidine. We illustrate the application of this approach for the purification of human Bruton’s tyrosine kinase (Btk), which results in highly efficient binding and elution of bait protein in both purification steps (>50% recovery).
    [Show full text]
  • Simulations of Я-Hairpin Folding Confined to Spherical Pores Using
    Simulations of ␤-hairpin folding confined to spherical pores using distributed computing D. K. Klimov*†, D. Newfield‡, and D. Thirumalai*† *Institute for Physical Science and Technology, University of Maryland, College Park, MD 20742; and ‡Parabon Computation, 3930 Walnut Street, Suite 100, Fairfax, VA 22030-4738 Communicated by George H. Lorimer, University of Maryland, College Park, MD, April 12, 2002 (received for review December 18, 2001) 3 ϱ We report the thermodynamics and kinetics of an off-lattice Go radius of gyration of a chain Rg at D (the size of a chain in ␤ Ӎ ␯ model -hairpin from Ig-binding protein confined to an inert bulk solution) to N according to Rg aN . If the chain is ideal, ␯ ϭ ⌬ ϭ ͞ 2 spherical pore. Confinement enhances the stability of the hairpin then 0.5 and FU RTN(a D) . Because of the reduction due to the decrease in the entropy of the unfolded state. Compared in the translational entropy, confinement also increases the free ⌬ Ͼ ⌬ ͞⌬ ϽϽ with their values in the bulk, the rates of hairpin formation increase energy of the native state, i.e., FN 0. If FN FU 1, then in the spherical pore. Surprisingly, the dependence of the rates on localization of a protein in a confined space stabilizes the native the pore radius, Rs, is nonmonotonic. The rates reach a maximum state compared with the bulk. It also follows that there is a range ͞ b Ӎ b at Rs Rg,N 1.5, where Rg,N is the radius of gyration of the folded of D values over which stability is maximized.
    [Show full text]
  • Analysis of Proteins by Immunoprecipitation
    Laboratory Procedures, PJ Hansen Laboratory - University of Florida Analysis of Proteins by Immunoprecipitation P.J. Hansen1 1Dept. of Animal Sciences, University of Florida Introduction Immunoprecipitation is a procedure by which peptides or proteins that react specifically with an antibody are removed from solution and examined for quantity or physical characteristics (molecular weight, isoelectric point, etc.). As usually practiced, the name of the procedure is a misnomer since removal of the antigen from solution does not depend upon the formation of an insoluble antibody-antigen complex. Rather, antibody-antigen complexes are removed from solution by addition of an insoluble form of an antibody binding protein such as Protein A, Protein G or second antibody (Figure 1). Thus, unlike other techniques based on immunoprecipitation, it is not necessary to determine the optimal antibody dilution that favors spontaneously-occurring immunoprecipitates. Figure 1. Schematic representation of the principle of immunoprecipitation. An antibody added to a mixture of radiolabeled (*) and unlabeled proteins binds specifically to its antigen (A) (left tube). Antibody- antigen complex is absorbed from solution through the addition of an immobilized antibody binding protein such as Protein A-Sepharose beads (middle panel). Upon centrifugation, the antibody-antigen complex is brought down in the pellet (right panel). Subsequent liberation of the antigen can be achieved by boiling the sample in the presence of SDS. Typically, the antigen is made radioactive before the immunoprecipitation procedure, either by culturing cells with radioactive precursor or by labeling the molecule after synthesis has been completed (e.g., by radioiodination to iodinate tyrosine residues or by sodium [3H]borohydride reduction to label carbohydrate).
    [Show full text]
  • Magresyn ® Protein G
    MagReSyn® Protein G Immobilized Protein G magnetic 1.4. Additional Equipment and Materials microparticles Magnetic separator, Vortex mixer, Buffers and solutions, end-over-end mixer (optional) Ordering Information Cat. No. Quantity 2. Immunoglobulin Purification Factors that may affect the attachment of antibodies include the isotype of the MR-PRG002 2 ml immunoglobulin, buffer composition and pH, and the presence of MR-PRG005 5 ml contaminants/interfering compounds. The quantity of microparticles needs to be optimized for each individual application. We recommend the application of excess MR-PRG010 2 x 5 ml ligand to ensure saturation of the Protein G microparticles. The binding efficiency can be determined by comparing the ligand concentration before and after coupling. This product is for research use only MagReSyn® Protein G is compatible with various commonly used buffers, including Tris and Phosphate. Recommended buffers include: Binding/wash buffer - TBS (50 mM Tris pH 7.5, 150 mM NaCl, 0.025% Tween® 20) or PBS (50 mM Phosphate pH 7.5, 150 mM Table of Contents: NaCl, 0.025% Tween® 20); Elution Buffer (Native): 0.1 M glycine pH 2.5 or 2.5% acetic 1. Product Description acid; Elution Buffer (Denaturing): SDS-PAGE electrophoresis buffer. 2. Immunoglobulin Purification 3. Immunoprecipitation NOTE: All reagents should be freshly prepared and of analytical grade to ensure 4. Recommended Storage optimal performance. The procedures, methods and buffer solutions described below serve as an example and are not intended to be limiting. MagReSyn® Protein G is 5. Antibody Binding Guide compatible with a range of different buffers for binding of antibodies.
    [Show full text]
  • 6511-Protein G-Sepharose
    FOR RESEARCH USE ONLY! Protein G-Sepharose rev. 09/16 ° Store at 4 C. Do not freeze. Cat. No. 6511-1 Protein G-Sepharose, 1 ml settled resin 6511-5 Protein G-Sepharose, 5 ml settled resin 6511-25 Protein G-Sepharose, 25 ml settled resin 6511-100 Protein G-Sepharose, 100 ml settled resin 6511-1000 Protein G-Sepharose, 1 L settled resin Support: 6% cross-linked Sepharose beads supplied as 50% slurry (e.g., 1 ml of settled resin is equivalent to 2 ml of 50% slurry) in 20% Ethanol/H2O. Binding Capacity: >20 mg human or rabbit IgG/ml of settled resin. Flow Rate Tested*: 0.85 cm/min. *Test condition: Linear flow rate determined in 2 ml column with internal diameter of 1.5 cm. Introduction: Protein G is a cell wall protein produced by group G streptococcus. Like protein A, this bacteria-derived protein binds with high affinity & specificity to the Fc portion of most mammalian immunoglobulins. Therefore, Protein G has been widely used for IgG purification. BioVision’s Protein G (Cat. # 6510) is a genetically engineered protein containing three Ig-binding regions of native Protein G. The cell wall binding region, albumin binding region and other non-specific regions have been eliminated from the recombinant Protein G to ensure the maximum specific IgG binding. The coupling technique is optimized to give a higher binding capacity for IgG & minimum leaching of recombinant Protein G. In addition, Protein G-Sepharose beads display high chemical & physical stability as well as high flow rate, hydrophilicity & high gel strength.
    [Show full text]
  • Protein G Agarose
    Protein G Agarose Item No Size 223-51-01 10 mL INTRODUCTION Table 1. Relative Affinity of Immobilized Protein G and Protein A for Various Antibody Species and Subclasses of Protein G Agarose consists of recombinant protein G, which is (8) produced in E. coli and after purification, is covalently polyclonal and monoclonal IgG’s . immobilized onto 4% cross-linked agarose beads. Protein G agarose is suitable for the isolation of IgG antibodies using Species/ Subclass Protein G Protein A column or immunoprecipitation methods. DNA sequencing of MONOCLONAL native protein G (from Streptococcal group G) has revealed Human two IgG-binding domains as well as sites for albumin and cell IgG 1 ++++ ++++ surface binding (1 - 6). Protein G has been designed to IgG 2 ++++ ++++ eliminate the albumin and cell surface binding domains to IgG 3 ++++ --- reduce nonspecific binding while maintaining efficient IgG 4 ++++ ++++ binding of the Fc region of IgG’s. With the removal of these binding domains, Protein G can be used to separate albumin Mouse from crude human IgG samples(7). IgG 1 ++++ + IgG 2a ++++ ++++ Covalently coupled Protein G Agarose has been widely used IgG 2b +++ +++ for the isolation of a wide variety of immunoglobulin IgG 3 +++ ++ molecules from several mammalian species. Protein G has greater affinity for many more mammalian IgGs than Protein Rat A (Table 1). IgG 1 + --- IgG 2a ++++ --- FORM/STORAGE IgG 2b ++ --- IgG ++ + Protein G Agarose is supplied in a total volume of 15 mL 2c consisting of 10 mL Protein G agarose suspended in 20% POLYCLONAL ethanol/PBS. Store at 2 - 8°C.
    [Show full text]
  • Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy
    toxins Article Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins Javier Ruiz-de-la-Herrán 1, Jaime Tomé-Amat 1,2 , Rodrigo Lázaro-Gorines 1, José G. Gavilanes 1 and Javier Lacadena 1,* 1 Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid 28040, Spain; [email protected] (J.R.-d.-l.-H.); [email protected] (J.T.-A.); [email protected] (R.L.-G.); [email protected] (J.G.G.) 2 Centre for Plant Biotechnology and Genomics (UPM-INIA), Universidad Politécnica de Madrid, Pozuelo de Alarcón, Madrid 28223, Spain * Correspondence: [email protected]; Tel.: +34-91-394-4266 Received: 3 September 2019; Accepted: 10 October 2019; Published: 12 October 2019 Abstract: Immunotoxins are chimeric molecules that combine the specificity of an antibody to recognize and bind tumor antigens with the potency of the enzymatic activity of a toxin, thus, promoting the death of target cells. Among them, RNases-based immunotoxins have arisen as promising antitumor therapeutic agents. In this work, we describe the production and purification of two new immunoconjugates, based on RNase T1 and the fungal ribotoxin α-sarcin, with optimized properties for tumor treatment due to the inclusion of a furin cleavage site. Circular dichroism spectroscopy, ribonucleolytic activity studies, flow cytometry, fluorescence microscopy, and cell viability assays were carried out for structural and in vitro functional characterization. Our results confirm the enhanced antitumor efficiency showed by these furin-immunotoxin variants as a result of an improved release of their toxic domain to the cytosol, favoring the accessibility of both ribonucleases to their substrates.
    [Show full text]
  • A Predictive Model of Antibody Binding in the Presence of Igg-Interacting Bacterial Surface Proteins
    bioRxiv preprint doi: https://doi.org/10.1101/2020.10.20.347781; this version posted October 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. A predictive model of antibody binding in the presence of IgG-interacting bacterial surface proteins Vibha Kumra Ahnlide1, Therese de Neergaard1, Martin Sundwall1, Tobias Ambjörnsson2, and Pontus Nordenfelt1 1Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden 2Computational Biology and Biological Physics, Department of Astronomy and Theoretical Physics, Lund University, Lund, Sweden Many bacteria can interfere with how antibodies bind to their surfaces. This bacterial antibody targeting makes it challeng- According to our previous findings (22), the IgGFc-binding ing to predict the immunological function of bacteria-associated of M and M-like proteins is more prominent in low IgG antibodies. The M and M-like proteins of group A streptococci concentration environments, corresponding to that of the exhibit IgGFc-binding regions, which they use to reverse IgG human throat milieu. At the higher IgG concentrations in binding orientation depending on the host environment. Unrav- plasma, IgG is mostly bound to the surface proteins via eling the mechanism behind these binding characteristics may identify conditions under which bound IgG can drive an effi- Fab. This suggests that the antibody binding orientation is cient immune response. Here, we have developed a biophysi- dependent on the IgG concentration.
    [Show full text]
  • Protein Structure Databases and Classification
    Protein Structure Databases and Classification •SCOP, CATH classification schemes, what they mean. •Motifs: classic turn types. Extended turn types. •TOPS: drawing a protein molecule The SCOP database • Contains information about classification of protein structures and within that classification, their sequences • Go to http://scop.berkeley.edu SCOP classification heirarchy global characteristics (no (1) class evolutionary relation) (2) fold Similar “topology” . Distant (3) superfamily evolutionary cousins? (4) family Clear structural homology (5) protein Clear sequence homology (6) species functionally identical unique sequences protein classes 1. all α (126) number of sub-categories 2. all β (81) 3. α/β (87) 4. α+β (151) 5. multidomain (21) 6. membrane (21) 7. small (10) 8. coiled coil (4) 9. low-resolution (4) possibly not complete, or 10. peptides (61) erroneous 11. designed proteins (17) class: α/β proteins Mainly parallel beta sheets (beta-alpha-beta units) Folds: TIM-barrel (22) swivelling beta/beta/alpha domain (5) spoIIaa-like (2) flavodoxin-like (10) restriction endonuclease-like (2) ribokinase-like (2) Many folds have historical names. chelatase-like (2) “TIM” barrel was first seen in TIM. These classifications are done by eye, mostly. fold: flavodoxin-like 3 layers, α/β/α; parallel beta-sheet of 5 strand, order 21345 Superfamilies: 1.Catalase, C-terminal domain (1) Note the term: “layers” 2.CheY-like (1) 3.Succinyl-CoA synthetase domains (1) These are not domains. 4.Flavoproteins (3) No implication of 5.Cobalamin (vitamin B12)-binding domain (1) structural independence. 6.Ornithine decarboxylase N-terminal "wing" domain (1) Note how beta sheets are 7.Cutinase-like (1) described: number of 8.Esterase/acetylhydrolase (2) strands, order (N->C) 9.Formate/glycerate dehydrogenase catalytic domain-like (3) 10.Type II 3-dehydroquinate dehydratase (1) fold-level similarity common topological features catalase flavodoxin At the fold level, a common core of secondary structure is conserved.
    [Show full text]
  • Recombinant Human Igg4 Fc Protein
    Leader in Biomolecular Solutions for Life Science Recombinant Human IgG4 Fc Protein Catalog No.: RP00801 Recombinant Sequence Information Background Species Gene ID Swiss Prot As a monomeric immunoglobulin that is predominately involved in the secondary Human P01861 antibody response and the only isotypethat can pass through the human placenta, Immunoglobulin G (IgG) is synthesized and secreted by plasma B cells, Tags andconstitutes 75% of serum immunoglobulins in humans. IgG antibodies protect No tag the body against the pathogens byagglutination and immobilization, complement activation, toxin neutralization, as well as the antibody-dependent cell-mediated Synonyms cytotoxicity (ADCC). IgG tetramer contains two heavy chains (50 kDa ) and two light Ig gamma-4 chain C region;IgG4 Fc chains (25 kDa) linked bydisulfide bonds, that is the two identical halves form the Y-like shape. IgG is digested by pepsin proteolysis into Fabfragment (antigen- binding fragment) and Fc fragment ("crystallizable" fragment). IgG1 is most abundant in serum amongthe four IgG subclasses (IgG1, 2, 3 and 4) and binds to Fc receptors (FcγR ) on phagocytic cells with high affinity. Fc fragmentis Product Information demonstrated to mediate phagocytosis, trigger inflammation, and target Ig to particular tissues. Protein G or Protein A onthe surface of certain Staphylococcal Source Purification and Streptococcal strains specifically binds with the Fc region of IgGs, and Human Cells > 95% by SDS- hasnumerous applications in biotechnology as a reagent for affinity purification. PAGE. Recombinant IgG Fc Region is suggested torepresent a potential anti- inflammatory drug for treatment of human autoimmune diseases. Endotoxin < 1 EU/μg of the protein by LAL Basic Information method.
    [Show full text]
  • Β-Barrel Oligomers As Common Intermediates of Peptides Self
    www.nature.com/scientificreports OPEN β-barrel Oligomers as Common Intermediates of Peptides Self-Assembling into Cross-β Received: 20 April 2018 Accepted: 22 June 2018 Aggregates Published: xx xx xxxx Yunxiang Sun, Xinwei Ge, Yanting Xing, Bo Wang & Feng Ding Oligomers populated during the early amyloid aggregation process are more toxic than mature fbrils, but pinpointing the exact toxic species among highly dynamic and heterogeneous aggregation intermediates remains a major challenge. β-barrel oligomers, structurally-determined recently for a slow-aggregating peptide derived from αB crystallin, are attractive candidates for exerting amyloid toxicity due to their well-defned structures as therapeutic targets and compatibility to the “amyloid- pore” hypothesis of toxicity. To assess whether β-barrel oligomers are common intermediates to amyloid peptides - a necessary step toward associating β-barrel oligomers with general amyloid cytotoxicity, we computationally studied the oligomerization and fbrillization dynamics of seven well- studied fragments of amyloidogenic proteins with diferent experimentally-determined aggregation morphologies and cytotoxicity. In our molecular dynamics simulations, β-barrel oligomers were only observed in fve peptides self-assembling into the characteristic cross-β aggregates, but not the other two that formed polymorphic β-rich aggregates as reported experimentally. Interestingly, the latter two peptides were previously found nontoxic. Hence, the observed correlation between β-barrel oligomers formation and cytotoxicity supports the hypothesis of β-barrel oligomers as the common toxic intermediates of amyloid aggregation. Aggregation of proteins and peptides into amyloid fbrils is associated with more than 25 degenerative diseases, including Alzheimer’s disease (AD)1,2, Parkinson’s disease (PD)3,4, prion conditions5 and type-2 diabetes (T2D)6,7.
    [Show full text]
  • Predicting Protein Secondary and Supersecondary Structure
    29 Predicting Protein Secondary and Supersecondary Structure 29.1 Introduction............................................ 29-1 Background • Difficulty of general protein structure prediction • A bottom-up approach 29.2 Secondary structure ................................... 29-5 Early approaches • Incorporating local dependencies • Exploiting evolutionary information • Recent developments and conclusions 29.3 Tight turns ............................................. 29-13 29.4 Beta hairpins........................................... 29-15 29.5 Coiled coils ............................................. 29-16 Early approaches • Incorporating local dependencies • Predicting oligomerization • Structure-based predictions • Predicting coiled-coil protein interactions Mona Singh • Promising future directions Princeton University 29.6 Conclusions ............................................ 29-23 29.1 Introduction Proteins play a key role in almost all biological processes. They take part in, for example, maintaining the structural integrity of the cell, transport and storage of small molecules, catalysis, regulation, signaling and the immune system. Linear protein molecules fold up into specific three-dimensional structures, and their functional properties depend intricately upon their structures. As a result, there has been much effort, both experimental and computational, in determining protein structures. Protein structures are determined experimentally using either x-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy. While
    [Show full text]